Company Financials

Dallah Healthcare Company Financials

Saudi riyal

business Dallah Healthcare Company Company Profile

Main Stock Listing

Tadawul: 4004

Market Capitalization SR15.50 Billion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 32.88
Forward PE 31.02
Price to Sales TTM SR4.84
Price to Book MRQ SR4.55
Enterprise to Revenue 5.59
Enterprise to EBITDA 25.65

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2024-09-30
Profit Margin 14.70%
Operating Margin 19.04%
Return on Assets TTM 5.77%
Return on Equity TTM 13.95%

Income Statement

Revenue TTM SR3,202,985,984
Revenue per Share TTM SR32.85
Quarterly Revenue Growth 13.10%
Gross Profit TTM SR1,078,673,638
EBITDA SR782,901,782
Net Income to Common TTM SR470,950,080
Diluted EPS TTM SR4.83
Quarterly Earnings Growth YoY 27.60%

Balance Sheet

Total Cash MRQ SR208,219,488
Total Cash per Share MRQ SR2.13
Total Debt MRQ SR
Total Debt to Equity MRQ 55.01
Current Ratio MRQ 1.11
Book Value per Share MRQ SR34.92

Cash Flow

Operating Cash Flow TTM SR779,456,896
Levered Free Cash Flow TTM SR59,367,588

4004 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 97,589,600
Float Shares None
Avg 10 Volume 71,954
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 58.06%
% Held by Institutions 3.91%

Stock Price Summary

Beta
Fifty Two Week Low SR147.80
Fifty Two Week High SR194.00
Fifty Two Week Change -8.12%
Day 50 MA SR155.69
Day 200 MA SR163.77

Dividends and Splits

Forward Annual Dividend Rate SR2.00
Forward Annual Dividend Yield 1.27%
Trailing Annual Dividend Rate SR2.00
Trailing Annual Dividend Yield 1.27%
Payout Ratio 41.41%
Dividend Date
Ex Dividend Date 2024-11-14
Last Split Factor
Last Split Date 2020-09-14